Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.91

+1.5%

Nov 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1195)	7/8/2005 11:19:22 PM
From: Jibacoa	Read Replies (1) of 3722

ARIA Also was up more than 8% on volume of more than 1.455M It was initiated this week by BAC with a "buy" rating.<g> bigcharts.marketwatch.com It had a 58% increase in revenues in its March Q but the loss was almost double ($0.23/shr vs. $0.13/shr in 2004) and the EL for 2005 is up to $0.90/shr vs. $0.69/shr in 2004 On May 18 at ASCO it announced the results of its PII of mTOR inhibitor, AP23573,which showed "striking clinical benefit and symptomatic improvement" in patients with advanced sarcoma. And later in the month it announced a PIa on oral administration of AP23573, which has been assigned a "fast track" designation by the FDA (for whatever that is worth under its new Oncology Head, Dr.Richard Padzur <g>) And on June 30 it announced that it was starting a PII of its AP23573 on patients with recurrent or persistent endometrial Ca. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next